Edwards Lifesciences Corporation Stock Swiss Exchange
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.6 CHF | -1.45% |
|
-.--% | -.--% |
Jul. 10 | Citigroup Adjusts Price Target on Edwards Lifesciences to $106 From $105 | MT |
Jul. 02 | Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating | MT |
Sales 2024 * | 6.56B 5.88B | Sales 2025 * | 7.17B 6.42B | Capitalization | 55.95B 50.12B |
---|---|---|---|---|---|
Net income 2024 * | 1.61B 1.44B | Net income 2025 * | 1.88B 1.68B | EV / Sales 2024 * | 8.28 x |
Net cash position 2024 * | 1.64B 1.47B | Net cash position 2025 * | 2.75B 2.47B | EV / Sales 2025 * | 7.42 x |
P/E ratio 2024 * |
35.2
x | P/E ratio 2025 * |
30
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.59% |
Latest transcript on Edwards Lifesciences Corporation
![Extreme 47.5766666191](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 14-12-31 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 13-12-31 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 16-07-04 |
Chairman | 67 | 14-11-12 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-15 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.24% | 205B | |
+6.45% | 179B | |
+31.46% | 158B | |
+33.00% | 113B | |
+4.87% | 64.93B | |
-2.92% | 46.36B | |
-5.91% | 37.07B | |
+3.39% | 36.12B | |
+16.14% | 28.25B |
- Stock Market
- Equities
- EW Stock
- EW Stock